[18F]‐florbetaben PET/CT is sensitive for cardiac AL amyloidosis
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14270 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Raffaella Cassano Cassano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, Department of Clinical And Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Aniline Compounds, Positron Emission Tomography Computed Tomography, Stilbenes, Immunoglobulin Light-chain Amyloidosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Pisa.
Abstract (Originalsprache)
Often differential diagnosis between AL and ATTR amyloidosis is difficult. Concerning ATTR, sensitive diagnostic tool, as diphosphonate scintigraphy, was validated, instead of no imaging approach is as accurate in AL. Cardiac ultrasound and circulating biomarkers may raise the clinical suspicion but biopsy remains the only option for diagnosis. We aimed to explore the sensitivity of 18F-Florbetaben PET respect to blood tests or periumbilical fat (POF), cardiac, bone marrow (BM) or other tissues biopsies in a cohort of 33 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology Unit, Department of Clinical And Experimental Medicine, University of Pisa, Pisa, Italy.
- Division of Nuclear Medicine, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
- Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
- Interdisciplinary Center for Health Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
ORCID-Profile: Raffaella Cassano Cassano, Maria Livia Del Giudice
Förderung
- Università di Pisa
Zitieren
APA
Cassano Cassano, R., Genovesi, D., Vergaro, G., Giorgetti, A., Aimo, A., Del Giudice, M. L., Galimberti, S., Emdin, M., & Buda, G. (2024). [18F]‐florbetaben PET/CT is sensitive for cardiac AL amyloidosis. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14270
Vancouver
Cassano Cassano R, Genovesi D, Vergaro G, Giorgetti A, Aimo A, Del Giudice ML, et al. [18F]‐florbetaben PET/CT is sensitive for cardiac AL amyloidosis. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14270
BibTeX
@article{CassanoCassano2024,
author = {Cassano Cassano, Raffaella and Genovesi, Dario and Vergaro, Giuseppe and Giorgetti, Assuero and Aimo, Alberto and Del Giudice, Maria Livia and Galimberti, Sara and Emdin, Michele and Buda, Gabriele},
title = {[18F]‐florbetaben PET/CT is sensitive for cardiac AL amyloidosis},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14270}
}
EUVIMED